At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 54 enrolled
Drug / intervention
Venous Window Needle Guidedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vital Access Venous Window Needle Guide for Salvage of AV FistulaE (SAVE) Trial
In Brief
A Phase 3 clinical trial evaluating Venous Window Needle Guide for End Stage Renal Disease and 2 related conditions. Completed, enrolled 54 participants across 2 sites.
Detailed Summary
The SAVE Study will evaluate the safety and efficacy of the Venous Window Needle Guide in achieving access of a deep, un-cannulatable arteriovenous fistula to complete hemodialysis as prescribed.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEnd Stage Renal Disease, AV Fistula, Kidney Failure
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 2011
Enrollment StartDec 2011
Primary CompletionMar 2013
Study CompletionJun 2013
TodayJul 2026
First PostedNov 11, 2011
Enrollment StartDec 1, 2011
Primary CompletionMar 1, 2013
Study CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 14.6 years ago
Interventions
Venous Window Needle Guidedevice
Subcutaneous, extravascular needle guide made of medical-grade titanium